The FDA says the device, designed to repair broken blood vessels to stem bleeding, showed a “clinically meaningful benefit.” ...

A Durham biotechnology company has seen its stock price plummet over the past few days amid a stock offering and a media ...

With this funding, Entvin plans to expand its artificial intelligence capabilities and accelerate customer acquisition ...

Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.

The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Pharmaceutical firms may consult with health authorities individually to speed up process under streamlined drug approval ...

Dr. Laura Niklason, President and CEO of Humacyte, Inc. (NASDAQ:HUMA), responded to a New York Times (NYSE:NYT) article that questioned the FDA’s approval of Symvess for commercial sales earlier this ...

The HHS Secretary has issued a directive to stop a loophole that lets companies approve their own food additives. Here's what ...

The FDA launches sweeping changes to food safety rules that could transform grocery aisles nationwide as untested ingredients ...

Shares of Tonix Pharmaceuticals are pulling back 12.7% during Thursday's session. The stock is pulling back following a regulatory update on its experimental fibromyalgia treatment, TNX-102 SL.

The new framework aims to shorten the time on register new medications in Israel, making drugs more readily available to the ...